Pennington Biomedical researchers will present scientific findings and participate in expert discussions at ObesityWeek 2026, highlighting advances in obesity science and treatment. The institution will also contribute to educational and early-career programming.
Endometrial cancer rates have increased substantially among Native American and Hispanic women, diagnosed at younger ages, with significant disparities in healthcare access. Research highlights the need for increased awareness, earlier detection, and targeted interventions to address these disparities and reduce cancer-related deaths.
China has more prevalent cases of pancreatic cancer (103,000 vs. 66,000), but lower age-standardized rates, compared to the US. The US has higher age-standardized rates of incidence, mortality, and disability-adjusted life years (DALYs), attributed to high fasting plasma glucose being the leading risk factor
A pilot study found that 10 people with chronic diabetic foot ulcers experienced complete wound closure within six months and improved sensation in the treated feet. The study's encouraging findings support further investigation into placental stem cell therapies.
Carol J. Levy, MD, CDCES, has been appointed as Chief of the Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai Health System. Dr. Levy brings extensive experience in diabetes care, research, and education, having led the Mount Sinai Diabetes Center and established the outpatient artificial pancreas program.
Viacure Therapeutics, a spin-off from Helmholtz Munich, is developing an antibody therapy to protect insulin-producing beta cells and restore their function in type 2 diabetes. The therapy aims to preserve or regenerate beta cells, supporting the body's ability to regulate blood glucose.
The Endocrine Society establishes the Jesse Roth Award to recognize outstanding research in hormone action, diabetes, or metabolism. C. Ronald Kahn is the inaugural winner, who will deliver a lecture at ENDO 2027 and receive an honorarium and travel grant.
A recent study found that eating peanuts was associated with favorable changes in blood lipids linked to a lower risk of type 2 diabetes. The changes involved a class of lipids called sphingolipids, which contained very long-chain saturated fatty acids.
Researchers at Bar-Ilan University have identified two blood biomarkers that can predict which mice will respond to a combination therapy for autoimmune diabetes, leading to long-term remission in one-third of treated mice. The study also showed that the treatment stimulated pancreatic regeneration, offering new insights into potential...
The study found that counties with higher poverty, food insecurity, and physical inactivity also had higher diabetes prevalence. Researchers identified 'cold spots' with lower diabetes rates, suggesting that these areas may hold clues for prevention strategies.
Researchers review how AI enhances continuous glucose monitoring to enable predictive, personalized diabetes management, improving glycemic outcomes and prioritizing high-risk patients. Machine learning models forecast individualized responses to meals, enabling tailored dietary and physical activity guidance.
Five new research hubs will develop tools to detect early signs of illness, such as dementia and traumatic brain injuries, and prevent them. The hubs will bring together experts from across the UK to create innovative solutions, including AI-powered brain health clinics and computer models to predict brain injury risk.
Research from Karolinska Institutet found that people with type 2 diabetes, heart disease, or stroke who sleep well perform better on cognitive tests and have larger brain volumes than those who sleep poorly. This study suggests that healthy sleep may help mitigate the negative effects of cardiometabolic disease on brain health.
A randomized controlled trial found that adding sleep coaching to a diabetes prevention lifestyle program helped participants sleep better and feel less sleepy during the day, leading to greater weight loss. Falling asleep earlier was associated with about 1.3 pounds of weight loss over eight weeks, independent of sleep duration.
An 8-month program providing medically tailored meals improved diet quality and access to healthy food for adults with Type 2 diabetes and high blood pressure. Gradually reducing meal frequency did not decrease health benefits when complemented with a heart health curriculum.
A new study found that GLP-1 medications may be more effective than metformin in preventing Type 2 diabetes and reducing heart risks in people with prediabetes and obesity. The research analyzed health records of over 250,000 adults and found that GLP-1 medications reduced the risk of heart attack and stroke more than metformin.
Diabetic foot ulcers cause pain despite numbness, with patients experiencing unpredictable and severe discomfort. Patients struggle to manage their daily lives due to sleep disturbances and lack of pain recognition from healthcare staff.
Research highlights a 30% higher risk of critical congenital heart disease in babies born to women with chronic hypertension or diabetes before or during pregnancy. The study emphasizes the importance of monitoring blood pressure and receiving appropriate care before and during pregnancy to reduce the risk of fetal heart defects.
Dr. Petter Bjornstad will lead Pennington Biomedical Research Center in advancing research in metabolic disease, with a focus on improving the health and well-being of Louisiana residents. He brings exceptional expertise in diabetes and kidney disease, with a vision to translate world-class science into better health outcomes.
Researchers developed an AI model using retinal images to diagnose diabetic nephropathy and predict progression, avoiding kidney biopsies. The model achieved high accuracy and robust performance, showing great clinical value in kidney disease diagnosis and management.
Researchers found that sotagliflozin reduces excessive platelet activation, a process that can lead to dangerous blood clots that block flow to the heart and brain. The drug also makes platelets less likely to stick together and form blood clots, potentially lowering the risk of heart attack and stroke.
Chronic kidney disease in China has seen rising prevalence, with 156 million people affected in 2023, largely driven by type-2 diabetes and hypertension, with obesity remaining a significant risk factor, and a disparity between men and women in disease burden
A new guide, Football for Diabetes, adapts football training for people with type 2 diabetes or prediabetes, focusing on individual abilities and enjoyment. The 12-week training programme combines warm-up, ball exercises, and small-sided games to benefit physical and mental well-being.
A European study found associations between air pollution, temperature variability, and blood glucose levels in people without diabetes. Greater exposure to air pollution, particularly PM10 particles, and increases in temperature and temperature variability were linked to higher blood glucose levels.
Researchers discovered a protein called Miro1 linked to insulin resistance in muscle, offering a potential new target for future diabetes treatments. Removing Miro1 restored muscle response to insulin in preclinical models, while exercise reduced protein levels in people with Type 2 diabetes.
A new study by UCL researchers highlights the importance of monitoring blood sugar and weight changes during the first 90 days after starting antipsychotic treatment. The study found significant metabolic changes during this period, particularly among patients with prediabetes and those who take certain antipsychotic medications.
A large-scale clinical trial found that adults using continuous glucose monitors (CGMs) spent approximately 5 additional hours each day within their target blood sugar range compared to those receiving routine care. Nearly twice as many CGM users achieved an A1c level below 7%, a common treatment goal for people with diabetes.
A team of researchers found that carbonic anhydrase VIII (CA8) coordinates insulin secretion and hepatic glucose production in mice with type 2 diabetes. The study reveals that CA8 plays a crucial role in regulating metabolic functions in the liver and pancreas.
Researchers found that eating olive oil before carbohydrates reduces early blood glucose levels and slows gastric emptying in mice, while also increasing early secretion of glucagon, GIP, and GLP-1. These beneficial effects were retained in mice with type 2 diabetes and severe insulin deficiency.
UCLA scientist Tara TeSlaa is developing a new approach to record nutrient use in specific cell types, aiming to build maps of cellular metabolism across tissues and conditions. Her lab will use stable isotope tracing to create a molecular record of nutrient use, allowing for more accurate interpretations of nutrition research.
A human trial has shown that the diabetes drug empagliflozin reduces inflammatory cell clumps and promotes metabolic reprogramming in patients with obesity and prediabetes. This finding suggests that the medication may have heart-protective benefits beyond weight loss.
Researchers found that minimally and highly processed meals with matched nutritional profiles produced distinct metabolic responses and activity in the brain's reward system. The study suggests that food processing may affect how the body and brain respond to food, potentially leading to overconsumption and long-term health effects.
Research found that unfavorable social determinants of health are associated with a higher risk of dementia in adults with and without type 2 diabetes, with particularly strong associations observed among women with T2D. The study also found that diabetes-related dementia risk varies across social environments.
The study found a 24-fold increase in new GLP-1 prescriptions among new mothers, with women with type 2 diabetes and gestational diabetes showing the highest rates. Prescribing increased fastest among those diagnosed as obese or overweight before pregnancy.
A new study finds that high fasting glucose has surpassed tobacco use as the leading risk factor for pancreatic cancer in the US, while China faces a dual metabolic-tobacco burden. China recorded more absolute cases, but lower age-standardized rates, with a peak burden at ages 60-74.
Researchers found substitution effects between obesity-labeled and diabetes-labeled GLP-1 receptor agonists, which vary by state coverage policies. The study suggests that these effects could impact coverage decisions for obesity treatment in Medicaid.
Researchers have found that an oral medication called Danegaptide can protect against vision-threatening damage in Non-Proliferative Diabetic Retinopathy (NPDR), a leading cause of blindness in working-age adults. The study highlights a new therapeutic approach that could replace or complement frequent, invasive eye injections for mill...
Researchers found that strokes among adults ages 20-54 nearly doubled over nearly three decades, even as short-term survival after stroke improved. The increase was driven by ischemic stroke, with rates rising from 23.8 cases per 100,000 person-years in 1993-1994 to 47.3 cases per 100,000 person-years in 2020.
A preliminary study led by UC San Francisco found that reducing ultra-processed food intake significantly improved symptoms of depression and anxiety in participants, who reduced their intake by over 85%.
A new study found that eating with a companion reduces blood glucose spikes and improves glucose recovery, suggesting that human physiology is inherently social. The researchers call this principle Social Physiology, which states that the human body regulates itself more efficiently in the presence of social partners.
A new study published in Childhood Obesity found that nearly one in six children prescribed GLP-1 medications experience nutritional deficiencies, with vitamin D being the most common, within one year.
Researchers at Pennington Biomedical developed GVC-Calc to analyze continuous glucose monitoring data, providing a scalable and transparent approach. The platform supports batch processing, integrates individual-level data with cohort-level results, and offers consensus clinical metrics alongside exploratory measures.
Dr. Mark Walker led a seminar on pre-eclampsia, a condition that affects 2-4% of pregnancies and can be life-threatening. The seminar reviews current knowledge, strategies for prevention, and highlights a critical global health challenge, particularly in low-income and middle-income countries.
Researchers identified a distinct risk profile for young adults with early-onset fatty liver disease, associated with genetic factors and metabolic conditions like type 2 diabetes. The study highlights the need for more accurate liver screening and assessment for individuals at greatest risk.
The EASD has published its first evidence-based clinical practice guideline on diabetes distress, emphasizing the importance of assessing and managing emotional burdens in adults with type 1 and type 2 diabetes. The guideline aims to improve clinical care and outcomes by incorporating a person-centered approach to diabetes care.
UCLA researchers are launching a phase 1/2 clinical trial to evaluate the safety and efficacy of JAK inhibitors in preventing immune checkpoint inhibitor-induced type 1 diabetes. The trial aims to test whether these drugs can protect insulin-producing cells in patients who develop diabetes after cancer immunotherapy.
A new study suggests that individuals with diabetes who focus on tightly controlling their blood sugar levels may be missing out on enjoyable activities due to the associated burden. Higher glucose variability and better sleep quality on the previous day were associated with improved quality of life on the following day.
A clinical trial found significant improvements in pain and sensation in people with treatment-resistant painful diabetic neuropathy after receiving spinal cord stimulation. The study also observed early evidence of increased density of small nerve fibers in the skin, which may indicate potential long-term benefits.
A new study by KTU researchers explores whether artificial intelligence can uncover patterns in glucose data to predict changes and assess hypoglycaemia risk. The model achieved high accuracy in forecasting glucose levels and performing well on patients with unseen data.
A new study found that weight loss injection semaglutide may reduce asthma attacks by up to 40% in people with airways diseases like asthma and COPD. Semaglutide also led to a 20% reduction in COPD flare-ups.
The INSULIN Act would cap out-of-pocket insulin costs at $35 per month for people on private insurance, establishing a resource center and hotline for uninsured individuals. The Endocrine Society applauds the bipartisan bill, which aligns with its Insulin Access and Affordability Position Statement.
A study found that SGLT2 inhibitors increase the risk of ketoacidosis in patients with type 2 diabetes who have high blood glucose, low body weight, or a history of ketoacidosis. The risk persists throughout treatment duration, highlighting the need for better support for high-risk patients.
A nationwide study found that early initiation of statins after type 2 diabetes diagnosis was associated with a 15% lower relative risk of dementia over 10 years. Statin treatment was also linked to a 10% lower risk of dementia in patients who initiated treatment between one and five years after diagnosis.
Researchers found that impaired peroxisomal function can increase insulin secretion while promoting insulin oxidation and disrupting pancreatic beta cell maturity. Healthy peroxisomes play a role in protecting insulin from oxidative modification and degradation, and helping beta cells maintain their specialized characteristics.
A study found that higher breastfeeding intensity is associated with more favorable early postpartum lipid profiles among women with prior gestational diabetes. Greater breastfeeding intensity may be linked to a more favorable early cardiometabolic profile in these women.
A clinical trial found that a ketogenic diet significantly improves metabolic health in people with obesity, with 50% of participants no longer meeting the criteria for prediabetes. The diet also showed the greatest improvements in liver health and insulin sensitivity.
The University of Louisville is launching the Nutrition and Metabolic Health Center to tackle chronic diseases, with a focus on prevention and new treatments. Researchers will investigate the impact of nutrition and environmental factors on health, with the goal of improving prevention and treatment options.
Researchers developed a risk calculator that estimates short-term risk of diabetes complications using routine health data. The tool analyzes insurance claims and electronic health record data to provide monthly, encounter-level risk estimates.
The 2026 Childhood Obesity Conference, 'Be the Reason Kids Greaux Healthy,' will explore strategies for preventing and treating childhood obesity, bringing together healthcare professionals, researchers, educators, and community leaders. The conference will feature keynotes, sessions, and poster presentations on emerging topics in pedi...
A study found that type 2 diabetes in lean Africans is caused by a shortage of insulin, not insulin resistance, unlike in overweight individuals. This disparity leads to different disease processes and treatment responses, with lean patients often developing eye damage and strokes, while overweight patients are more likely to have high...